As the life span of patients with cystic fibrosis (CF) has gradually increased, a variety of problems, like osteoporosis, have been recognized. Hypovitaminosis D, hypogonadism, lack of physical activity and chronic inflammation are some of the factors that contribute to the pathogenesis of bone disease in CF patients. Decreased absorption of vitamin K because of pancreatic insufficiency could be another risk factor for osteoporosis. The aim of the study was to determine the implication of vitamin K in the pathogenesis of osteoporosis in CF children and adolescent. We studied 20 patients with CF (ten boys) aged 6 to 7 years old and 25 healthy subjects of similar age and sex. All patients were evaluated before and 1 year after vitamin K supplementation. In all patients and controls serum carboxy-terminal propeptide of procolagen type I (PICP), amino-terminal propeptide of procolagen type I (PINP), bone alkaline phosphatase (sALP), osteocalcin (OC), cross-linked carboxy terminal telopeptide of type 1 collagen (ICTP), vitamin D, parathormone (PTH) and undercarboxylated osteocalcin (GLU-OC) were determined. Urine deoxypyridinoline/creatinine was also determined. Bone density was measured only in the patients using dual-energy x-ray absorptiometry (DEXA). Our results indicated that 55% of CF patients had osteoporosis. The supplemented patients showed: a)increase of bone density (0.789Ϯ0.149 than 0.737 Ϯ 0.151, pϽ0.0001), b) increase of PINP (579.35Ϯ275.11microg/l than 341.65Ϯ270.77microg/l, pϽ0.0001) c) increase of PICP (341.30Ϯ140.53 microg/l than 290.06Ϯ117.64microg/l, pϽ0.011) d)increase of sALP (51.75Ϯ14.94microg/l than 45.28Ϯ20.48 microg/l, pϽ0.024) e)increase of oc (26.22Ϯ14.25ng/ml than 15.45Ϯ11.62ng/ml, pϽ0.004) f)decrease of GLU-OC (2.28Ϯ3.93ng/ml than 6.60Ϯ6.24, pϽ0.004). According to our results, vitamin K supplementation in CF children and adolescent improves BMD by enhancing osteoblast activity. 
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ESTROGEN ATTENUATES OLIGODENDROCYTE APOPTOSIS CAUSED BY HYPEROXIA
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Background: In the developing human brain, periventricular leukomalacia (PVL) is the predominant white matter injury underlying the development of cerebral palsy. Our group recently showed that a rise of oxygen tissue tension is a powerful trigger to initiate apoptosis in premature and immature, but not in mature oligodendrocytes (OL). Estrogen plays an important role in the development and function of the cerebral nervous system, and estrogen receptors show a specific distribution with high density arround the third ventricle, the region where OL progenitors are generated. We therefore examined the effects of estrogen on hyperoxia-induced cell death in cultured rat immature oligodendroglia cells.
Methods: OLN-93 cells, derived from spontaneously transformed cells of 5-to 10-day-old primary rat brain oligodendrocytes were subjected to 24 -72 h of hyperoxia (80% O2) in the presence or absence of estrogen (17beta-estradiol) at various concentrations. These immature oligodendrocytes resemble an intermediate stage between oligodendrocyte precursors and mature oligodendrocytes. Flow cytometry was used to assess apoptosis via annexin-V, anti-activated caspase-3 antibody, and propidium iodide staining. Oligodendrocyte maturation status and caspase-3 activation were confirmed by immunochemistry.
Results: In immature rat oligodendrocytes (OLN-93), apoptosis was detected at various stages (early: annexin-V, effector: caspase-3) after 24 -72 h of hyperoxia (80% O2). Cell death was reduced up to 30% by preincubation with estrogen at a concentration optimum of 10 -7 M estrogen.
Conclusion: Estrogen reduces apoptosis in immature oligodendrocytes exposed to hyperoxia. The sudden drop in circulating estrogen of placental origin after mammalian birth may aggravate the susceptibility of immature oligodendrocytes to increased oxygen tension. Supported by grants from the German Federal Department of Education and Research (BMBF, # 01 ZZ 0101), Bonn, and the Ernst Schering Research Foundation, Berlin.
EVALUATION OF METABOLIC & RESPIRATORY DISORDERS IN IN-FANTS OF DIABETIC MOTHERS (IDM)

S GHAEMI 1 , M MOHAMADY MASOUDI 1 1 S GHAEMI ISFAHAN UNIVERSITY OF MEDICAL SCIENCES , 2 M-MOHAMADY MASOUDI ISFAHAN UNIVERSITY OF MEDICAL SCIENCES (IRAN)
Background: Control of diabetes mellitus with insulin during pregnancy has led to improved outcomes in children. Poorly controlled maternal diabetes is associated with problems in the fetus and neonate. Fetal and neonatal hyperinsulinism is central to many of these problems. The incidence of respiratory, metabolic, hematologic and cardiac problems is higher in IDM. The aim of this research was to detect the prevalence rate of some common metabolic & respiratory problems in IDM.
Material & methods:
The research involved a descriptive analytic study carried out on 200 neonates of diabetic mothers admitted to the Al-zahra & Beheshti hospitals in Isfahan, Iran, between July 1995 and August 1999.
Results: A group of 100 (50%) out of 200 IDM had metabolic disorders, (53% females and 47% males). Hypoglycemia, hyperbilirubinemia and hypocalcaemia were common metabolic complications with a frequency of 37.5%, 30% and 10% respectively. 48 (24%) of the 200 IDM had respiratory distress, (52.1% males, 47.9% females). All complications were more common in preterm infants than term infant, metabolic disorders were 75% in preterm versus 25% term, and respiratory disorders were 70.8% in preterm versus 29.2% term. Hypocalcaemia & respiratory distress were more common in male than in female infants and hypoglycemia & hyperbilirubinemia were more common in females than males.
Conclusions: Metabolic and respiratory disorders were more common in IDM than infants of non-diabetic mothers. Preterm status was a predisposing factor for developing complications in IDM.
EVALUATION OF SURFACTANT THERAPY IN HMD AND REDUCTION OF MORTALITY
S GHAEMI 1 , M MOHAMADY MASOUDI 1 1 ISFAHAN UNIVERSITY OF MEDICAL SCIENCE,IS-FAHN ISFAHAN, (IRAN)
HMD Occurs Primarily in premature infants, and its incidence is inversely proportional to gestational age and birth weight. HMD is a Major cause of morbidity and mortality in preterm neonates. (about 30%) Surfactant deficiency is the primary cause of HMD in Previous studies, surfactant therapy has reduced mortality from HMD approximately 40% the aim of this research was determined the incidence of mortality in neonates with HMD after treatment with surfactant. Methods & materials: In this study that was a descriptive analytic study, we evaluated 450 neonates with HMD, who were admitted to NICU in Results: A group of 34 (38.2%) out of 89 neonates who received surfactant survived HMD , on the other hand , in this study surfactant therapy has reduced mortality from HMD (38.2%), 42% were females and 36.2% were males. The most efficacy of surfactant therapy and low mortality were observed on gestational age more than 32 weeks, and therapy in the Ist 24 hr of life (47.5%and 43.3% respectively). Also the most efficacy of surfactant were showed in APGAR score at 1 , 5 min more than 7/10 and in birth weight more than 1500 Gr (48% and 52.5% respectively). In this study , mothers who received steroid before delivery and their neonates who took surfactant after birth , had the most efficacy and reduction of mortality (41.7% with steroid and 34.15% without steroid).
CONCLUSIONS: The purpose of this study was detection the prevalence rate of reduction of mortality after surfactant therapy in HMD, our study was showed reduction of mortality and also was concluded the most efficacy of surfactant therapy on some condition which associate with HMD.
